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Abstract
Biotin-dependent enzymes catalyze carboxyl transfer reactions
by efficiently coordinating multiple reactions between spatially distinct
active sites. Pyruvate carboxylase (PC), a multifunctional biotindependent enzyme, catalyzes the bicarbonate- and MgATP-dependent
carboxylation of pyruvate to oxaloacetate, an important anaplerotic
reaction in mammalian tissues. To complete the overall reaction, the
tethered biotin prosthetic group must first gain access to the biotin
carboxylase domain and become carboxylated and then translocate to
the carboxyltransferase domain, where the carboxyl group is
transferred from biotin to pyruvate. Here, we report structural and
kinetic evidence for the formation of a substrate-induced biotin binding
pocket in the carboxyltransferase domain of PC from Rhizobium etli.
Structures of the carboxyltransferase domain reveal that R. etli PC
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occupies a symmetrical conformation in the absence of the biotin
carboxylase domain and that the carboxyltransferase domain active
site is conformationally rearranged upon pyruvate binding. This
conformational change is stabilized by the interaction of the conserved
residues Asp590 and Tyr628 and results in the formation of the biotin
binding pocket. Site-directed mutations at these residues reduce the
rate of biotin-dependent reactions but have no effect on the rate of
biotin-independent oxaloacetate decarboxylation. Given the
conservation with carboxyltransferase domains in oxaloacetate
decarboxylase and transcarboxylase, the structure-based mechanism
described for PC may be applicable to the larger family of biotindependent enzymes.
Keywords: Biotin, Decarboxylase, Enzyme Catalysis, Enzyme Kinetics,
Enzyme Mechanisms, Enzyme Structure, Pyruvate Carboxylase

Introduction
Biotin-dependent enzymes catalyze carboxyl transfer reactions
on a range of metabolically important substrates and are widely
distributed across all three domains of life (recently reviewed in Refs.
1 and 2). This family of enzymes includes acetyl-CoA carboxylase,
propionyl-CoA carboxylase, the oxaloacetate decarboxylase complex,
transcarboxylase, and pyruvate carboxylase, all of which act in central
metabolism and serve to maintain cellular homeostasis. Pyruvate
carboxylase (PC3; EC 6.4.1.1) catalyzes the bicarbonate- and MgATPdependent carboxylation of pyruvate to oxaloacetate. This important
anaplerotic reaction serves to replenish oxaloacetate in the
tricarboxylic acid cycle, where intermediates are routinely funneled to
other metabolic pathways, such as gluconeogenesis in the liver (3),
fatty acid biosynthesis in adipose tissue (4), neurotransmitter
biosynthesis in astrocytes (5, 6), and glucose-mediated insulin
secretion in pancreatic islets (7). Type II diabetes (8, 9), tumor cell
proliferation (10–12), and bacterial virulence (13, 14) are all
associated with aberrant PC expression levels and enzyme activity.
In all eukaryotes and most prokaryotes, PC is a homotetramer.
Each monomer is composed of four functional domains: the biotin
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carboxylase (BC) domain, the carboxyltransferase (CT) domain, the
biotin carboxyl carrier protein (BCCP) domain, and the central
allosteric domain. The N-terminal BC domain initiates the overall
reaction by catalyzing the MgATP- and bicarbonate-dependent
carboxylation of biotin. The carboxylated biotin cofactor, which is
covalently tethered via an amide linkage to the side chain of a strictly
conserved lysine in the BCCP domain, then physically translocates ∼60
Å across the subunit cleft to a neighboring CT domain active site where
the carboxyl moiety is transferred to the acceptor substrate, pyruvate
(15–18).
The chemical mechanisms for the individual BC (19) and CT (20)
domain reactions have been well characterized. For example, in the CT
domain of Rhizobium etli PC (RePC), Thr882 acts to shuttle a proton
from the biotin enolate to pyruvate (20), whereas Arg548, Gln552, and
Arg621 serve to stabilize the pyruvate enolate (16, 21, 22) (Scheme 1).
Furthermore, there is ample kinetic evidence suggesting that the
spatially distinct reactions in the BC and CT domains are remarkably
well coordinated (23). However, the molecular basis for this
coordination remains largely unknown. Recently, we reported
structures of RePC suggesting that BCCP-biotin is precluded from the
BC domain active site following carboxylation (18). This protects
against the abortive decarboxylation of carboxybiotin in the BC domain
that would result in an energetically wasteful decoupling of ATP
hydrolysis from pyruvate carboxylation (19).
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SCHEME 1.
The proposed carboxyltransferase reaction mechanism in R. etli PC.

Although a mechanism to protect against abortive
decarboxylation has been proposed for the BC domain, it is not yet
clear whether a related mechanism exists in the CT domain.
Interestingly, PC-carboxybiotin is quite stable in the absence of
substrates, but several competitive inhibitors of pyruvate are sufficient
to invoke the translocation and decarboxylation of N[14C]carboxybiotin in the CT domain (24). These experiments imply
that 1) carboxybiotin can rapidly decarboxylate in the CT domain, even
in the absence of the bona fide acceptor substrate, and 2) a CT
domain ligand is required to facilitate biotin access to the CT domain
active site. It is clear from structural studies (16) and kinetic isotope
effects (25) that PC catalyzes biotin decarboxylation in the CT domain
without direct transfer of the carboxyl group from biotin to pyruvate.
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However, existing structural models are unable to explain how the CT
domain ligand facilitates biotin access and decarboxylation. This
difficulty stems, in large part, from an absence of directly comparable
structures of PC.
Here we report a series of directly comparable structures and
accompanying kinetic studies that reveal a substrate-induced biotin
binding pocket in the CT domain of RePC. The active site of the CT
domain undergoes a conformational change upon pyruvate binding.
This conformational rearrangement, which is stabilized by the
interaction of conserved Asp590 and Tyr628 in RePC, results in formation
of the biotin binding pocket. Due to the conserved nature of both
Asp590 and Tyr628 and similar active site architecture in homologous
biotin-dependent enzymes, we hypothesize that the structural
mechanism described here for PC is applicable to the broader family of
biotin-dependent enzymes.

Experimental Procedures
General
Isopropyl 1-thio-β-D-galactopyranoside, D-biotin, ampicillin,
kanamycin, chloramphenicol, DL-dithiothreitol (DTT), epoxysuccinyl-Lleucylamido(4-guanido) butane, and pepstatin A were purchased from
Research Products International Corp. (Mount Prospect, IL). Malate
dehydrogenase and lactate dehydrogenase were purchased from
Roche Applied Science. Acetyl-CoA was purchased from Crystal Chem,
Inc. (Downers Grove, IL). All other materials were purchased from
Sigma-Aldrich. RePC and ΔBC RePC were previously subcloned into a
modified pET-17b and pET-28a vector, respectively, for expression in
λ(DE3) lysogenized Escherichia coli (15, 18).

Site-directed Mutagenesis and Domain Truncation
Mutations
The Y628F, Y628A, and D590A mutations were generated using
the QuikChange site-directed mutagenesis protocol (Agilent
Technologies, Santa Clara, CA) and were verified by complete
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sequencing of the gene by Functional Biosciences, Inc. (Madison, WI).
For the BCCP domain truncation, it was determined that Ala1067
represents the N-terminal end of the BCCP domain based on the x-ray
crystal structure of RePC (PDB code 2QF7). The BC and BCCP domain
deletion construct (ΔBCΔBCCP RePC) was therefore generated via the
QuikChange protocol by incorporating two stop codons after the codon
for Ala1067 in an expression vector encoding the BC domain truncation
of RePC (18). The resulting ΔBCΔBCCP RePC construct retains the
complete allosteric and carboxyltransferase domains of RePC. Identical
mutagenic oligonucleotide primers were used to generate the Tyr628
and Asp590 mutations in both full-length RePC and ΔBCΔBCCP RePC.
Oligonucleotide primers were synthesized by Integrated DNA
Technologies (Coralville, IA).

RePC and ΔBCΔBCCP RePC Protein Production and
Purification
RePC and all mutant forms of the full-length enzyme were coexpressed with the pCY216 vector encoding E. coli biotin protein ligase
(BirA) in E. coli BL21Star(DE3) cells from a modified pET-17b vector as
described previously (18). Cells were cultured in M9 minimal medium
containing 200 mg/liter ampicillin and 30 mg/liter chloramphenicol. At
an optical density (600 nm) of 0.8–0.9 and prior to induction with 1
m isopropyl 1-thio-β-D-galactopyranoside and 20 m L-arabinose,
D-biotin and MnCl2 were supplemented into the growth medium to 3
mg/liter and 0.1 m, respectively. Cultures were induced for 16–20 h
at 16 °C.
ΔBCΔBCCP RePC and all of its mutant forms were expressed in E. coli
BL21Star(DE3) cells from a modified pET28a-His8-TEV vector as
described previously (18). Cells were cultured in M9 minimal medium
containing 40 mg/liter kanamycin. When the culture reached an optical
density (600 nm) of 0.8–1.0, MnCl2 was supplemented in the growth
medium to 0.1 m, followed by induction with 1 m isopropyl 1-thioβ-D-galactopyranoside for 16–20 h at 16 °C.
All forms of RePC were purified using Ni2+ affinity and anion
exchange chromatography. Harvested cells were resuspended in Buffer
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A, containing 20 m Tris-HCl (pH 7.8), 5 m imidazole, 200 m NaCl,
0.5 m EGTA, 6 m 2-mercaptoethanol, 1 m phenylmethanesulfonyl
fluoride (PMSF), 1 μm pepstatin A, and 5 μm epoxysuccinyl-Lleucylamido(4-guanido) butane. Cells were disrupted by sonication,
and the cell lysate was cleared by centrifugation at 10 °C prior to
loading onto a 10-ml Ni2+-nitrilotriacetic acid Profinity resin column
(Bio-Rad). The enzyme was eluted from the column in Buffer A, with a
gradient from 20 to 250 m imidazole. Purified protein was pooled
and dialyzed overnight against Buffer A at 4 °C. For all forms of
ΔBCΔBCCP RePC, the Ni2+-nitrilotriacetic acid-purified preparation was
incubated in Buffer A with His-tagged recombinant tobacco etch virus
(rTEV) protease at 4 °C (40:1 molar ratio of ΔBCΔBCCP RePC to rTEV
protease) to remove the N-terminal His8 tag. After His8 tag cleavage,
the ΔBCΔBCCP RePC sample was reapplied to a Ni2+ affinity column to
remove the cleaved His8 tag and His-tagged rTEV protease. The His8
tag cleavage and rTEV protease removal was >95% efficient as
estimated by SDS-PAGE (data not shown). Cleaving the N-terminal
His8 tag of the full-length RePC with rTEV protease was unsuccessful,
suggesting that the recognition sequence is inaccessible to the rTEV
protease. Therefore, all full-length forms of RePC retained the
recombinant N-terminal His8 tag.
All purified protein samples were pooled and dialyzed in Buffer
B, containing 20 m triethanolamine (pH 8.0), 50 m NaCl, 1 m
EGTA, and 2 m DTT at 4 °C, in preparation for anion exchange
chromatography. Protein was loaded on a 10-ml column volume of QSepharose Fast Flow resin (GE Healthcare) and was sequentially eluted
from the resin in Buffer B using a linear gradient from 50 m to 1 m
NaCl. Fractions were pooled and dialyzed against a storage buffer
consisting of 10 m Tris-HCl (pH 7.8), 50 m NaCl, 10 m MgCl2, 5%
(v/v) glycerol, and 2 m DTT. MgCl2 was deliberately excluded from
all buffers during purification of wild-type and mutant forms of
ΔBCΔBCCP RePC. An Amicon stirred cell with a 30,000 molecular
weight cut-off filter was used to concentrate protein preparations to a
range of 3–12 mg/ml. Concentrated protein was flash frozen in liquid
nitrogen prior to storage at −80 °C. Full-length RePC and ΔBCΔBCCP
RePC enzyme concentrations were determined spectrophotometrically
using the calculated molar extinction coefficient of 118,000 m−1 cm−1
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and 76,780 m−1 cm−1, respectively, at 280 nm (26). All full-length
purified RePC proteins were >95% biotinylated, as revealed by an
avidin-gel shift assay (data not shown) (20).
Protein Crystallization
Wild-type and the Y628A mutant form of ΔBCΔBCCP RePC were
crystallized under similar conditions using the batch crystallization
method under oil. Crystallization conditions for all x-ray crystal
structures were nearly identical. For the ΔBCΔBCCP RePC structure cocrystallized with pyruvate, a protein solution consisting of 10 mg/ml
ΔBCΔBCCP RePC and 30 m pyruvate was mixed at a 1:1 ratio with a
precipitant solution composed of 12–14% (w/v) PEG 8000, 100 m
BisTris (pH 6.0), 300–400 m tetramethylammonium chloride, and
2% (v/v) glycerol. The Y628A mutant was co-crystallized with 50 m
pyruvate. A seed stock was created using the seed bead kit from
Hampton Research (Aliso Viejo, CA). Briefly, a single apoprotein
ΔBCΔBCCP RePC crystal was pulverized in 500 μl of precipitant
solution, and 0.5 μl of the seed solution was added to the
crystallization drop immediately following mixing. The drop was
covered with paraffin oil, and diamond-shaped crystals (250 μm × 200
μm × 150 μm) formed within 2–3 days. After 5–7 days, the crystals
were serially transferred in 5% (v/v) glycerol increments from a
synthetic mother liquor solution consisting of 10% (w/v) PEG 8000, 65
m BisTris (pH 6.0), 200 m tetramethylammonium chloride, 5%
(v/v) glycerol, and 25 m NaCl to a cryoprotectant solution consisting
of 11.5% (w/v) PEG 8000, 90 m BisTris (pH 6.0), 350 m
tetramethylammonium chloride, 20% (v/v) glycerol, and 25 m NaCl
and flash cooled in liquid nitrogen.
Data Collection and Structure Determination
X-ray diffraction data were collected at the Advanced Photon Source,
beamline LS-CAT (Life Sciences Collaborative Access Team) 21-ID-F
and 21-ID-G, on Rayonix MarMosaic 225 CCD and 300 CCD detectors,
respectively. In all cases, the x-ray wavelength was tuned to 0.979 Å.
Diffraction images were processed with the HKL2000 suite (27). In all
cases, the diffraction data were anisotropic, with diffraction falling off
in the b* direction relative to the a* and c* directions. This contributed
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to the modest resolution limits and to the elevated Wilson B-value.
Anisotropic data truncation using the UCLA MBI diffraction anisotropy
server did not improve the electron density maps or the refinement
statistics and was therefore not used for data processing. The
structures were solved by molecular replacement using the CT +
allosteric domains of the wild-type RePC enzyme (PDB code 2QF7) as
the search model with the program Phaser (28). Following molecular
replacement, translation/liberation/screw (TLS) refinements were
performed using REFMAC (29–31). Initial B-factors were set at a
constant value of 20.0 Å2 prior to the start of refinement. Each
monomer was treated as a rigid TLS group. TLS refinement improved
the 2Fo − Fc maps and lowered the final R and Rfree for each model by
1.5 and 3.0%, respectively, consistent with what is expected from
using a single TLS group model (32). All four monomers in the
asymmetric unit were restrained using non-crystallographic symmetry
for all models during the entire refinement process. The models were
extended by several rounds of manual model building with COOT (33)
and successive refinements with REFMAC. Water molecules were
added to the model in COOT with subsequent manual verification. In
all cases, monomers A and B are packed more tightly in the
asymmetric unit than monomers C and D. As a result, monomers A
and B exhibit lower B-factors (Table 1) and are better defined by the
electron density maps. All figures were generated from monomer A of
the structure. Data collection and processing statistics are summarized
in Table 1.
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Pyruvate Carboxylation Assay
Pyruvate carboxylation activity was determined
spectrophotometrically by measuring the conversion of oxaloacetate to
malate using malate dehydrogenase, as described previously (22).
Reaction assays were initiated by the addition of RePC (3–150 μg) in a
1-ml reaction volume at 25 °C. All enzyme substrates were maintained
at saturation except for pyruvate, which was varied from 0 to 50 mm.
Each reaction was performed in 0.1  Tris-HCl (pH 7.8), 25 m
NaHCO3, 2.5 m MgATP, 7 m MgCl2, 0.25 m acetyl-CoA, 0.24 m
NADH, and malate dehydrogenase (10 units).

Phosphorylation of MgADP Using Carbamoyl Phosphate
The phosphorylation of MgADP in the presence of carbamoyl
phosphate was measured by following the production of ATP using a
hexokinase/glucose-6-phosphate dehydrogenase coupled assay (20,
22, 34). Specific activities were determined at 25 °C in 3-ml reaction
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mixtures containing 0.1 m Tris-HCl (pH 7.8), 7 m MgCl2, 3.5 m
MgADP, 0.25 m acetyl-CoA, 20 m carbamoyl phosphate, 0.4 m
glucose, 0.36 m NADP, glucose-6-phosphate dehydrogenase (5
units), and hexokinase (2 units). The reaction was initiated by the
addition of RePC (200 μg).

Oxaloacetate Decarboxylation in the Presence and
Absence of Oxamate
The PC-catalyzed rate of oxaloacetate decarboxylation was
determined by measuring the reduction of pyruvate to lactate using
lactate dehydrogenase (20, 22, 35). Reactions were performed in 0.1
m Tris-HCl (pH 7.8), 0.25 m acetyl-CoA, 0.24 m NADH, and lactate
dehydrogenase (10 units). For reactions catalyzed by ΔBCΔBCCP
RePC, 1 m oxaloacetate was added prior to initiation of the reaction
with enzyme (400–900 μg). The half-life for the spontaneous
decarboxylation of oxaloacetate is 2–6 h at room temperature (36).
Therefore, oxaloacetate solutions were prepared fresh, kept on ice for
the duration of the kinetic experiments, and added immediately prior
to initiation of the reaction. The enzyme-catalyzed rate was obtained
by subtracting the slow rate of non-enzymatic oxaloacetate
decarboxylation from the rate measured in the presence of the
enzyme. Biocytin or biotin was supplemented into these reactions at a
final concentration of 5 m. Reactions exhibited substrate inhibition in
the presence of oxamate (0.5 m); therefore, rates were determined
at both 0.2 and 1 m oxaloacetate. All reactions were conducted in a
1-ml reaction volume at 30 °C.

Results and Discussion
Active Site Remodeling in the Carboxyltransferase
Domain during Substrate Binding
A small number of PC structures have been reported (15, 16,
18, 21), but direct comparisons between these structures have been
complicated by differences in the source organism and in the set of
bound ligands. To date, there are no directly comparable structures of
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the CT domain of PC in the presence and absence of pyruvate. After
screening several engineered constructs of RePC, it was determined
that removing both the BC and BCCP domains (ΔBCΔBCCP RePC)
rendered the enzyme more amenable to crystallization. The relative
ease of crystallization afforded a unique opportunity to directly
investigate the structural perturbations accompanying substrate
binding in the CT domain of PC. Consequently, ΔBCΔBCCP RePC was
crystallized with and without the bona fide substrate, pyruvate. The
protein crystallized in the space group P212121 under all cocrystallization conditions. The unit cell contains four monomers of
ΔBCΔBCCP RePC, arranged as a dimer of dimers. In all structures, one
homodimer is composed of chains A and C, whereas the second
homodimer is composed of chains B and D. All four monomers of
ΔBCΔBCCP RePC include a pyruvate molecule bound in the active site
when co-crystallized with pyruvate. Representative electron density for
chain A is presented in Fig. 1A.
FIGURE 1.
Substrate binding leads to active site remodeling in the CT domain of RePC. A,
stereo view of representative electron density for the active site of ∆BC∆BCCP RePC
co-crystallized with pyruvate. The 2Fo―Fc electron density map is contoured to 1.0 σ
and is represented as a gray mesh. The 2Fo―Fc omit density map is contoured to 3.0 σ
and is represented as a green mesh. The representative electron density is for
monomer A. Electron density is not averaged. The modeled atoms correspond to the
final submitted coordinates. B, stereo view of the active site from the CT domain upon
pyruvate binding. The positioning of the orange loop is from the x-ray crystal structure
devoid of pyruvate. Pyruvate is colored green. The multiple conformations for Arg621
were modeled from RePC wild-type (PDB code 2QF7). C, structural alignment of the
pyruvate-bound ∆BC∆BCCP RePC with the H. sapiens PC crystal structure (PDB code
3BG3; monomer B; r.m.s. deviation = 1.3 Å) reveals the expected positioning of biotin
in the CT domain active site of RePC. In the closed conformation, Asp590 and
Tyr628 form a surface to assist with biotin insertion into the active site.
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As described previously, the CT domain architecture consists of
a canonical α8β8 TIM barrel fold with a large C-terminal funnel,
composed of nine α-helices, that leads into the active site at the
mouth of the barrel. The active site is centered on a structurally
conserved Lewis acid metal. Mutation of several conserved, metalcoordinating residues results in a loss of enzymatic activity in PC (37).
PC enzymes from vertebrates predominantly bind Mn2+, whereas yeast
and bacteria prefer Zn2+ (38). However, x-ray fluorescence analysis of
the ΔBCΔBCCP RePC crystals indicates the presence of both Mn2+ and
Zn2+ (data not shown), suggesting that RePC may be partially
indiscriminate in its metal ion preference. Given that this may be an
artifact of expression and purification from a heterologous host, further
analyses of RePC purified from source are needed to unequivocally
establish the physiological metal preference.
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The structures in the presence and absence of pyruvate enable,
for the first time, an analysis of conformational changes that
accompany substrate binding in the CT domain of PC. The most
pronounced difference between the structures determined in the
presence and absence of pyruvate lies within a flexible loop (Arg621–
Asn630), which forms a portion of the CT domain active site. In the
absence of substrate, the loop occupies an open conformation. The
side chain of Tyr628 is oriented away from the metal center, and the
guanidinium group of Arg621 is disordered (Fig. 1B, orange). This
disordered side chain is consistent with multiple conformations
observed for Arg621 in the higher resolution (2.0 Å) apo-structure of
RePC (15). When pyruvate is bound, the active site loop adopts a
closed conformation over the pyruvate binding site (Fig. 1B, cyan).
The loop movement coincides with the formation of a salt bridge
between the carboxyl moiety of pyruvate and the guanidinium group
of Arg621. Mutation of the equivalent residue to Arg621 in
Staphylococcus aureus PC (SaPC) resulted in a nearly complete loss of
PC enzyme activity, indicating an important role for this residue in
catalysis (21). The guanidinium group of Arg621 is within hydrogen
bonding distance to the backbone carbonyl oxygen of Val626 and Gly627
on the active site loop. These interactions are likely to stabilize the
closed conformation of the loop. In the closed conformation, the
tyrosyl moiety of Tyr628 rotates inward toward the active site, bringing
it within hydrogen bonding distance of the carboxyl group from Asp590
that is located opposite the active site cleft. The positioning of Asp590
appears to be aided by the guanidinium side chain of Arg594, which is
located within 2.5 Å of the carboxyl group of Asp590. Based on an
overlay with the x-ray crystal structure of pyruvate-bound Homo
sapiens PC, tethered biotin binds in the active site with its thiophene
ring positioned directly above the aromatic ring of Tyr628 (Fig. 1C).
Taken together, these structures suggest that the CT domain
active site receives carboxybiotin only after pyruvate is bound, when
the active site loop has been remodeled into the closed conformation.
These structural insights trace a direct connection between pyruvate
binding and the subsequent formation of the biotin binding site in the
CT domain and serve to significantly advance the description of how
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PC and related biotin-dependent enzymes affect the control and
coordination of biotin-dependent catalysis between remote active sites.
Substrate analogs that contain both the carboxyl and oxo
groups of pyruvate, such as fluoropyruvate, hydroxypyruvate,
oxamate, and glyoxylate, are inhibitors of the CT domain reaction of
PC (reviewed in Ref. 39). Further, these compounds are sufficient to
invoke the translocation and spontaneous decarboxylation of N[14C]carboxybiotin in the CT domain of PC from sheep liver (24).
However, propionate, lactate, and acetaldehyde, which lack either the
carboxyl or oxo groups, do not invoke decarboxylation of N[14C]carboxybiotin (24). The conformational remodeling observed in
ΔBCΔBCCP RePC structures indicates that pyruvate binding leads
directly to carboxybiotin insertion in the active site of the CT domain
and explains why only close analogs of pyruvate are able to invoke
carboxybiotin translocation and decarboxylation. X-ray crystal
structures of ΔBCΔBCCP RePC co-crystallized with oxamate, oxalate,
3-bromopyruvate, or 3-hydroxypyruvate all occupy the binding site for
pyruvate and promote the closed conformation of the CT domain.4
The conformational remodeling observed for the ΔBCΔBCCP
RePC structures in the presence and absence of pyruvate is consistent
with previously reported structures of PC. In the structure of SaPC cocrystallized with pyruvate (PDB code 3BG5), all four CT domain active
sites of the tetramer have pyruvate bound and exhibit a closed
conformation. Further, the BCCP domain is observed interacting with
one of the four CT domains with biotin extending into the active site
(16). In the only apparent contradiction of our hypothesis, the
structure of T906A SaPC (SaPC Thr906 is equivalent to RePC Thr882;
PDB code 3HBL) reveals biotin extending into the active site in the
absence of pyruvate (21). Based on this observation, the authors
suggest that pyruvate binding is not needed to facilitate BCCP-biotin
docking in the active site. However, a lobe of well defined positive
electron density occupies the binding site for pyruvate in the T906A
SaPC structure and locks the guanidinium side chain of Arg644
(equivalent to RePC Arg621) into a fixed conformation, suggesting that
T906A SaPC is not a true apo-structure. The unidentified molecule
occupying this lobe of electron density promotes the closed
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conformation, thereby accommodating BCCP-biotin insertion into the
active site of the CT domain, consistent with our proposed model.
Consequently, all reported structures of PC that reveal tethered biotin
in the active site also have a ligand occupying the pyruvate binding
site, consistent with our hypothesis.
Substrate-induced conformational remodeling also occurs in the
α subunit of the oxaloacetate decarboxylase complex (ODC). Structural
superposition of the Cα atoms of the CT-CT dimer from ΔBCΔBCCP
RePC with the CT-CT dimer of ODC from Vibrio cholerae (PDB code
2NX9) reveals a nearly identical active site architecture and dimer
interface, with an r.m.s. deviation of 2.2 Å. The x-ray crystal structure
of the CT domain from V. cholerae ODC was determined in the
absence of substrate, and the active site displays an open
conformation (40). Red edge excitation shift and FTIR data on V.
cholerae ODC demonstrate that ligand binding restricts the tryptophan
microenvironment and promotes structural changes in the CT domain
(41). This suggests that structural rearrangements accompany
substrate binding in the CT domain of homologous biotin-dependent
enzymes.

Steady State Kinetic Analysis of Asp590 and Tyr628
Mutations
Structures of the RePC CT domain suggest an important
contribution from Asp590 and Tyr628 to catalysis. Both amino acid
residues are conserved in all PC enzymes and in the CT domain of the
homologous biotin-dependent enzymes, ODC and transcarboxylase. To
determine the role of Asp590 and Tyr628 in the carboxylation of
pyruvate, Y628F, Y628A, and D590A mutations were generated in
RePC by site-directed mutagenesis, and the modified enzymes were
assessed for their catalytic activity. The Km for pyruvate, kcat, and
kcat/Km were determined for the wild-type and mutant forms of RePC.
For the overall reaction, starting from HCO3−, MgATP, and pyruvate, all
three mutations resulted in a pronounced effect on the Km for
pyruvate, kcat, and kcat/Km for pyruvate carboxylation (Table 2).
Removing the hydroxyl moiety from Tyr628 (Y628F) resulted in a 7-fold
reduction in kcat, whereas the Y628A mutation resulted in a 780-fold
Journal of Biological Chemistry, Vol. 288, No. 27 (July 2013): pg. 19915-19925. DOI. This article is © American Society for
Biochemistry and Molecular Biology and permission has been granted for this version to appear in ePublications@Marquette. American Society for Biochemistry and Molecular Biologydoes not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from American Society for
Biochemistry and Molecular Biology.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

reduction in kcat. The Tyr628 mutations also resulted in a sizable
increase in the Km for pyruvate, which contributed to the ∼80-fold and
∼20,000-fold decrease in catalytic efficiency for Y628F and Y628A,
respectively. Mutating Asp590 to Ala resulted in a 6-fold increase in Km
for pyruvate and a 350-fold decrease in kcat/Km.

TABLE 2
Catalytic activities of full-length RePC mutants compared with wild type for
the pyruvate carboxylation reaction. Reaction conditions were as follows: 100 mm
Tris-HCl (pH 7.8), 25 °C, 25 mm NaHCO3−, 7 mm MgCl2, 2.5 mm MgATP, 0.25 mm
acetyl-CoA, pyruvate (0–50 mm). Errors reported are the S.E. values from the nonlinear regression fit of the data to the Michaelis-Menten equation.

Although these mutations are located within the CT domain and
disrupt the ability of the enzyme to carboxylate pyruvate, previous
studies suggest that mutations in the CT domain can influence the rate
of reactions in the neighboring BC domain (20). To evaluate the effects
of these mutations on the BC domain activity, the specific activities for
the phosphorylation of MgADP using carbamoyl phosphate as the
phosphoryl donor were determined (Table 3). All mutations resulted in
only a minor reduction in the ability of the BC domain to phosphorylate
MgADP at saturating substrate concentrations.

TABLE 3
Catalytic activities of full-length RePC mutants compared with wild type for
the ADP phosphorylation reaction using carbamoyl phosphate reaction.
Reaction conditions were as follows: 100 mm Tris-HCl (pH 7.8), 25 °C, 7 mm MgCl2,
3.5 mm MgADP, 0.25 mm acetyl-CoA, 20 mm carbamoyl phosphate.
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The preceding results indicate that the catalytic role of both
Asp
and Tyr628 is exclusive to the CT domain reaction. To date,
kinetic investigations of PC have demonstrated a significant effect of
free biotin in the BC domain reaction (19, 23, 42). However, no such
biotin dependence has been established in the CT domain reaction. To
further investigate the role of Asp590 and Tyr628 in the CT domain
reaction, the biotin-dependent and biotin-independent rates of
oxaloacetate decarboxylation in the wild-type and mutant forms of
ΔBCΔBCCP RePC were measured. The biotin-dependent
decarboxylation of oxaloacetate involves a carboxyl transfer from
oxaloacetate to biotin, thus forming carboxybiotin (20, 25). However,
PC also catalyzes the decarboxylation of oxaloacetate in the absence of
biotin (22, 35). The truncation of the BC and BCCP domains from RePC
generates a unique and simplified system to investigate the effect of
free biotin on the rate of oxaloacetate decarboxylation.
590

At 1 m oxaloacetate, each ΔBCΔBCCP RePC mutation had a
modest effect on the biotin-independent rate of oxaloacetate
decarboxylation (Table 4). The Y628A ΔBCΔBCCP RePC mutation
represented the largest difference relative to wild type. The biotindependent decarboxylation of oxaloacetate was measured by
supplementing the reaction with biocytin and biotin. Biocytin, which
includes a lysine side chain fused to the valerate side chain of biotin, is
an ideal mimic of BCCP-biotin. The wild-type ΔBCΔBCCP RePC rate of
oxaloacetate decarboxylation increased by 5.6- and 1.9-fold in the
presence of 5 m biocytin and 5 m biotin, respectively (Table 4).
Notably, this biocytin-dependent rate enhancement is completely lost
in the Tyr628 and Asp590 mutations of ΔBCΔBCCP RePC. Only the D590A
ΔBCΔBCCP RePC exhibited a rate enhancement (3.1-fold) in the
presence of 5 m biotin, probably because the mutation eliminated
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the charge repulsion between Asp590 and the carboxylate moiety of
free biotin. These results unequivocally demonstrate that Asp590 and
Tyr628 are required to accommodate the binding of biotin in the CT
domain active site.

TABLE 4
Biotin- and biocytin-dependent oxaloacetate decarboxylation activities for
site-directed mutants of ΔBCΔBCCP RePC compared with wild-type ΔBCΔBCCP
RePC. Reaction conditions were as follows: 100 mm Tris-HCl (pH 7.8), 30 °C, 1 mm
oxaloacetate, 0.24 mm NADH.

Oxaloacetate decarboxylation was also assayed for the wild-type
and mutant forms of full-length RePC in the presence and absence of
oxamate (Table 5). Oxamate, a structural analog of pyruvate, serves
as a carboxyl acceptor from carboxybiotin in the CT domain; in the
presence of oxamate, the decarboxylation of oxaloacetate proceeds
through a double-displacement reaction mechanism with biotin acting
to shuttle CO2 from oxaloacetate to oxamate (43). Wild-type RePC
exhibits a kcat of 1.23 min−1 and 1.29 min−1 for the decarboxylation of
oxaloacetate when assayed at 1 and 0.2 m oxaloacetate,
respectively. At higher concentrations of oxaloacetate, the reaction is
subject to substrate inhibition in the presence of oxamate. Therefore,
the oxamate-induced decarboxylation of oxaloacetate was measured
at 0.2 m oxaloacetate. In the presence of 0.5 m oxamate, the rate
of oxaloacetate decarboxylation is enhanced 3-fold for wild-type RePC.
However, this rate enhancement is lost in the Tyr628 and Asp590
mutants. These results provide additional evidence that Tyr628 and
Asp590 are critical for the biotin dependence of RePC. The combined
kinetic data are fully consistent with our model; substrate binding in
the CT domain initiates the closure of the active site loop (Arg621–
Asn630), which is necessary for the formation of the biotin binding
pocket through the conserved interaction between Tyr628 and Asp590.
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TABLE 5
Catalytic activities of site-directed mutants of full-length RePC compared to
wild-type for the oxamate-induced decarboxylation of oxaloacetate. Reaction
conditions were as follows: 100 mm Tris-HCl (pH 7.8), 30 °C, 0.2 and 1 mm
oxaloacetate, 0.5 mm oxamate, 0.25 mm acetyl-CoA.

The X-ray Crystal Structure of Y628A ΔBCΔBCCP RePC
In order to further evaluate the role of Tyr628 in catalysis, we
crystallized the Y628A ΔBCΔBCCP RePC mutant in the presence of
pyruvate. The Y628A mutant has exactly the same overall
conformation as the wild-type ΔBCΔBCCP RePC. Structural
superposition of the Cα atoms from the Y628A ΔBCΔBCCP RePC dimer
with the dimers of ΔBCΔBCCP RePC co-crystallized in the presence and
absence of pyruvate yields an r.m.s. deviation of 0.2 and 0.3 Å,
respectively.
Of the four monomers in the asymmetric unit, only one member
of each homodimer pair (monomer A of CT dimer 1 and monomer B of
CT dimer 2) had pyruvate bound in the active site. Neither pyruvate
nor the guanidinium portion of Arg621 could be resolved in the active
site of monomers C and D. The active sites from monomers A and B
are equivalent to the active site for ΔBCΔBCCP RePC co-crystallized
with pyruvate, and the binding orientation of pyruvate in the active
sites from monomers A and B is unperturbed relative to the wild-type
enzyme (Fig. 2). The salt bridge interaction between the carboxyl
moiety of pyruvate and the guanidinium side chain of Arg621 is
retained, despite the loop being 2 Å further displaced from the metal
center. However, the positioning of the loop resembles the open
conformation observed for ΔBCΔBCCP RePC in the absence of
pyruvate.
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FIGURE 2
The interaction between Arg621 and pyruvate is unperturbed in the Y628A
ΔBCΔBCCP RePC crystal structure. Shown is a stereo view of the simulated
annealing omit map contoured at 3.0 σ for Arg621 and pyruvate (rose). The positioning
of pyruvate and the loop when the active site is in the closed conformation is
represented in cyan.

The structure of Y628A ΔBCΔBCCP RePC further supports a role
for Tyr628 in stabilizing the closed conformation of the active site. Upon
substrate binding, Tyr628 is repositioned such that the hydroxyl moiety
is within hydrogen bonding distance of Asp590 (see above). In the
Y628A mutation, the interaction with Asp590 is destroyed, and the
active site binds pyruvate but remains in the open conformation. The
biotin binding pocket cannot form in the open conformation, and
carboxybiotin insertion is prevented. The Y628A structure, therefore, is
fully consistent with the kinetic data showing that this mutant is not
activated by biocytin, biotin, or BCCP-biotin (Tables 4 and and55).
Our kinetic analyses reveal a clear discrepancy between the
Y628F and Y628A mutants of RePC. The Y628F RePC mutant is capable
of carboxylating pyruvate 250-fold more efficiently than the Y628A
RePC mutant, suggesting that the aromatic portion of Tyr628 plays a
specific role in catalysis. When biotin is bound in the active site of PC,
the sulfur atom of the thiophene ring is positioned over the aromatic
π-electron cloud of Tyr628 (16). There exists clear structural evidence
for the preferential localization of divalent sulfur (-CH2-S-CH3) at the
edge and slightly above the plane of aromatic rings, both in protein
stabilization and protein-ligand complexes (44, 45). A single sulfurJournal of Biological Chemistry, Vol. 288, No. 27 (July 2013): pg. 19915-19925. DOI. This article is © American Society for
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aromatic interaction is estimated to contribute 1–2 kcal/mol in
stabilization energy (46). Given that there are few specific interactions
serving to facilitate biotin binding in the CT domain active site (16),
the sulfur/π interaction between biotin and Tyr628 is expected to
contribute to carboxybiotin binding in the active site.

A Surprising Symmetrical Tetramer from R. etli PC
Complete structures of PC have been determined for the
enzyme cloned from R. etli and S. aureus (15, 16, 18, 21). In all
cases, the quaternary structure reveals a tetrameric rhombohedron
that is stabilized at the corners through homodimer interactions
between the BC and CT domains. However, despite ∼50% sequence
identity between SaPC and RePC, there have been striking differences
in the overall arrangement of the tetramers; the opposing faces of the
enzyme are highly asymmetrical in RePC, whereas they are nearly
symmetrical in SaPC (15, 16, 18, 21). The basis for this striking
deviation in quaternary structure remains unclear.
Truncation of the BC and BCCP domains in RePC offered an
opportunity to investigate the contribution of the CT domain to the
quaternary arrangement of the enzyme. To our surprise, two
ΔBCΔBCCP RePC dimers interact via their allosteric domains to form a
symmetrical tetramer (Fig. 3). The contacts between these opposing
allosteric domains are minimal, contributing only ∼320 Å2 of buried
surface area compared with ∼1400 Å2 of buried surface area for the
CT-CT homodimer interface. The most prominent contact between
allosteric domains is a parallel -stacking interaction between Phe1051
residues on opposing chains. This same interaction has been shown to
be essential for tetramerization in both H. sapiens PC and SaPC (16).
The symmetrical arrangement of the ΔBCΔBCCP RePC tetramer is in
good agreement with what has been observed both in SaPC and in a
BC domain truncation of H. sapiens PC (Fig. 3, A and B) but is in sharp
contrast with the asymmetrical tetramer of full-length RePC (Fig. 3C).
The CT-CT dimer structure is identical between the truncated and fulllength RePC; structural superposition of the Cα atoms of the CT-CT
dimer from ΔBCΔBCCP RePC with wild-type, full-length RePC reveals
an r.m.s. deviation of 0.3 Å. Therefore, the asymmetry observed in
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full-length RePC is likely to originate in the BC domain, which occupies
a much greater range of conformations than the CT domain in all x-ray
crystal structures of PC (15, 16, 18, 21).
FIGURE 3
The structure of the BC and BCCP domain truncation of RePC reveals a
symmetrical tetramer. The green and cyan domains represent the CT domain,
whereas the blue and magenta domains represent the allosteric/pyruvate carboxylase
tetramerization (PT) domains. The green and blue domains are located on the top face
of the tetramer, whereas the pink and cyan domains are on the bottom face. A,
structural alignment between the chain A and C homodimer of ΔBCΔBCCP RePC and
the chain A and D homodimer of ΔBC human pyruvate carboxylase (brown-colored,
semitransparent ribbons; PDB code 3BG3). B, structural alignment between the chain
A and C homodimer of ΔBCΔBCCP RePC and the chain A and D homodimer of the
allosteric + CT domains of the full-length S. aureus PC enzyme tetramer (yellowcolored, semitransparent ribbons; PDB code 3BG5). C, structural alignment between
the chain A and C homodimer of the ΔBCΔBCCP RePC and the chain A and B
homodimer of the allosteric + CT domains of the full-length RePC enzyme tetramer
(rose-colored, semitransparent ribbons; PDB code 2QF7).

Because the only data on the quaternary arrangement of PC
come from x-ray or cryo-EM data, it is not yet clear whether RePC and
SaPC are locked in these contrasting conformations or whether these
structures are reflective of a range of conformations in solution. The
surprising finding that RePC crystallizes as a symmetrical tetramer in
the absence of the BC and BCCP domains demonstrates that RePC can
access a wider range of conformations than previously recognized.
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In summary, we report structural and kinetic evidence for a
substrate-induced biotin binding pocket in the CT domain of PC. All
biotin-dependent enzymes must coordinate two independent reactions
in physically separate active sites. The translocation of tethered biotin
links these activities. Evidence is emerging that the individual active
sites are structured to control biotin access, thereby avoiding abortive
decarboxylation and ensuring efficient coupling between the BC and CT
domain reactions. According to our model, biotin is unable to bind in
the CT domain in the absence of a carboxyl group acceptor. In this
way, PC has evolved a mechanism to avoid the energetically wasteful
decoupling of ATP hydrolysis in the BC domain from pyruvate
carboxylation in the CT domain at physiological substrate
concentrations. Based on sequence conservation and similar structural
and biophysical evidence in ODC and transcarboxylase, we expect that
this general mechanism is applicable to the wider family of biotindependent enzymes.
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The abbreviations used are:

3

PC pyruvate carboxylase
BC biotin carboxylase
BCCP biotin carboxyl carrier protein
BisTris 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol
CT carboxyltransferase
ODC oxaloacetate decarboxylase complex
RePC and SaPC R. etli and S. aureus pyruvate carboxylase, respectively
rTEV protease recombinant tobacco etch virus protease
TLS translation/libration/screw
r.m.s. root mean square
PDB Protein Data Bank.
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